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The need for emergency cardiac bypass surgery due to a
complication occurring during a PCI procedure has gone
down from an initial 6–10 % in the early 1980s to less than
0.5 % in the present era [1]. Technological advances have
made the procedure very safe in the hands of experienced
operators working in dedicated centres. In Europe in the last
decade, many PCI programs without surgery on-site have
been started as a consequence of this rare need for actual
surgical back-up. In addition, these PCI programs were started
in (mostly rural) regions where travel distances to PCI centres
with surgery on-site resulted in long delays for STEMI pa-
tients undergoing primary PCI. The safety and long-term
efficacy outcome of PCI programs in centres without surgery
on-site have been shown in registries and large randomised
studies. Just recently, the MASS COMM investigators dem-
onstrated in a large randomised trial including 3691 patients
that there was no difference in the incidence of MACE at
30 days (9.5 % vs 9.4 %; RR 1.00; P<0.001 for non-
inferiority) and at 12 months (17.3 % vs 17.8 %; RR
0.98; P<0.001 for non-inferiority) [2]. These data con-
firm and extend the results from the CPORT study
published in 2012, which randomised 18,867 patients
and showed no difference in 6-week mortality and no
difference in MACE at 9 months (12.1 % vs 11.2 %;
P=0.05) [3]. Both these studies excluded patients un-
dergoing urgent PCI procedures for STEMI and
NSTEMI. Reports using non-randomised data from the
NRMI database by Pride et al., which included 58,821
STEMI patients and more than 100,000 NSTEMI pa-
tients treated either in centres with or without surgery
on-site confirmed that the safety (e.g., as assessed on
the basis of short-term mortality and need for emergen-
cy surgery) and efficacy (e.g., procedural success and
longer-term rate of survival) of such PCI procedures
was similar [4, 5].
Following these developments, the Dutch Guidelines
for Interventional Cardiology 2004 included recommen-
dations for centres and operators that provide PCI with-
out surgery on-site regarding facilities, staffing, training
requirements etc [6]. The minimum number of proce-
dures per centre and per operator are required in order
to ensure proficiency, experience and continued quality
of care. Moreover, structural relations with a surgical
centre and protocols for emergency transfer should be
present. In order to provide primary PCI for patients
with STEMI, a 24–7 service is required and finally,
centres are obliged to prospectively register procedures
and outcomes and submit these data to the Dutch Society of
Cardiology.
In this issue of the Netherlands Heart Journal, the experi-
ence of the first year of PCI procedures of the Venlo Percuta-
neous Coronary Intervention Program at VieCurie Medical
Centre Venlo and the six-month clinical outcome is reported
by Mol et al [7]. A total of 333 patients were included and, as
expected, the incidence of procedural complications and
MACE at 6 months was low, 5.7 % and 13.1 % respectively.
The results at 30 days were comparable to the earlier report by
Mol et al [7] from the Medical Center Alkmaar. The
authors are to be commended that they report their
results, illustrating efficacy and safety of a PCI program
without surgery on-site. Together with the data from the
literature, we can conclude that PCI without surgery on-
site is safe for selected patients when performed in
experienced hands in dedicated centres. It is convenient
for patients to be treated in a hospital nearby, and for
ACS patients it is probably cost-saving as it avoids
ambulance transfers.
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Several questions regarding the future quality of care in
PCI programs remain:
Has the outcome of STEMI patients undergoing primary PCI
improved with more hospitals offering this service at shorter
transfer distances? We live in a small country. Some remote
regions may have been underserved 10 years ago, but transfer
distances in the Netherlands are not very long, and adding 20–
30 min of transfer time is unlikely to have a major impact on
outcome. Outside office hours, cathlab staff travel to the
hospital while the patient is being transferred. Although avail-
ability of primary PCI has been an important argument for
starting new PCI programs, unfortunately systematic data are
not collected in order to demonstrate that the larger number of
hospitals providing this service results in a better outcome for
STEMI patients.
How do we select patients who should not undergo a PCI
procedure in a centre without on-site surgical back-up and
what do we tell patients? The European Guidelines on Myo-
cardial Revascularisation 2010 are quite clear on this issue: [8]
‘There is growing public demand for transparency regarding
site and operator results. Anonymous treatment should be
avoided. It is the patient’s right to know who is about to treat
him or her and to obtain information on the level of expertise
of the operator and the volume load of the centre. In addition,
the patient should be informed whether all treatment options
are available at the site and whether surgery is offered on-site
or not. Non-emergent high-risk PCI procedures, including
those performed for distal left main disease, complex bifurca-
tion stenosis involving large side branches, single remaining
coronary artery, and complex chronic total occlusion
recanalisation, should be performed by adequately experi-
enced operators at centres that have access to circulatory
support and intensive care treatment, and have cardiovascular
surgery on-site.’
How do we ensure that new technologies and best practices
that are developed together with the cardiac surgeons will find
their way to non-surgical sites? The Dutch guidelines stated
that: ‘Close cooperation with cardiac surgeons is essential for
a balanced assessment of the patient’s options. Elective or
acute interventional procedures should continuously be
compared with standards of cardiac surgery. Appropriate use
of new technology is recommended to keep up to date with
more difficult procedures.’ Appropriate decisions must be
reached together with a cardiac surgeon regarding concomi-
tant (trans-catheter) valve replacement, staged and hybrid
procedures, circulatory back-up, simultaneous treatment
for (surgical) atrial fibrillation, coronary revascularisation to-
gether with indications for ICD placement, resynchronisation
therapy, etc.
What is the optimal number of PCIs and how many PCI
centres are needed in the Netherlands? Table 1 shows the
number of sites performing PCIs and the total number of PCIs
each year. Total PCI volume has increased from 17,000 in
2000 to 35,000 in 2007 and to 42,000 in 2011. At the same
time, the number of PCI centres went from 13 in 2000 to 30 in
2011. At first glance, the growth in volume is paired by the
growth in number of centres, suggesting cathlab availability
drives volume. However, the increase in volume is (at least in
part) explained by the availability of centres for primary PCI
in regional systems, the general adoption of FFR measure-
ments for the assessment of coronary lesions and the recom-
mendation in the European Guidelines for non-STE-ACS
patients to adopt an early invasive strategy. In 2007, the
Netherlands ranked number seven in Europe in PCI/millions
inhabitants, behind countries such as Germany, Switzerland,
Norway and Latvia [9]. Is 42,000 PCIs the optimal number of
procedures? Importantly, there are no incentives within the
system to stabilise or reduce the number of procedures. With
the start of new PCI programs, investments have been made
and regional collaborations started. A volume of 600 proce-
dures with four operators may not be viable in the long run and
for centres to strive for a larger PCI volume, providing a return
on investment and the means to hire more operators, is the
obvious solution. Regional collaboration may encounter ten-
sions, however, when centres try to increase their catchment
area and compete for referrals. Depending on regional devel-
opments, if the optimal volume per centre is somewhere
between 1000 and 2000 procedures, 30 centres should suffice
when indications for PCI remain unchanged. In a cost-
conscious environment, balanced forces need to come into
play, with guidance from the Dutch Society of Cardiology in
collaboration with regulatory bodies.
Table 1 Number of PCI centers with and without on‐site surgery and number of PCI‐procedures in the Netherlands in the period 2000–2011
Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Centres with on-site surgery 13 13 13 14 16 16 16 16 16 16 16 16
Centres without on-site surgery 0 0 1 2 3 3 3 3 6 9 11 14
Number of PCIs 17,381 19,444 21,532 23,813 28,805 32,198 33,678 34,879 36,367 38,643 40,492 42,123
BHN Netherlands; NVVC; 3 July 2013
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